Pinsent Masons advises Bryan, Garnier & Co on Heidelberg Pharma AG’s capital increase

28 Jun 2021 | 02:23 pm |

Multinational law firm Pinsent Masons has advised Bryan, Garnier & Co on the successful EUR 20m capital increase of Heidelberg Pharma AG.

The transaction increased German based biopharmaceutical company Heidelberg Pharma AG’s share capital by approximately 10%, with the 3,106,637 newly issued shares offered to qualified institutional investors in Europe and the United States in an accelerated book-building process. At a subscription price of EUR 6.44 per share, the company raised gross proceeds of EUR 20 million.

The new shares were admitted to trading on the Frankfurt Stock Exchange on June 21, 2021.

Pinsent Masons advised Bryan, Garnier & Co, the sole global coordinator and sole bookrunner for the transaction. Bryan, Garnier & Co is one of the most active investment banks in the European growth sector, with a particular focus on healthcare, technology, consumer goods and business services. They are a fully registered broker-dealer, licensed and supervised by the FCA in Europe and FINRA in the US.

The Pinsent Masons team was led by Dr Susanne Lenz, LL.M. and included Roberta Markovina (Partner, London), Dušan Stojković (Senior Associate, Frankfurt) and Sara Šepac (Associate, Frankfurt).

Commenting on the transaction, Dr Susanne Lenz said:

"We are pleased to have worked with Bryan Garnier on this exciting and important transaction. With Heidelberg Pharma AG’s expertise in oncology, we are proud to have been part of the successful financing of a company on the cutting edge of biopharmaceutical research and development in Germany."

Latest press releases

Show me all press releases

Pinsent Masons has advised Tokai Carbon on the sale of its German subsidiary TOKAI ERFTCARBON GmbH

Multinational law firm Pinsent Masons has advised Tokai Carbon Co., Ltd. (“Tokai Carbon”) on the sale of its German subsidiary TOKAI ERFTCARBON GmbH (“TEG”), to Lenbach Equity Opportunities III. GmbH & Co. KG, which is exclusively advised by DUBAG Investment Advisory GmbH (“DUBAG”).

Pinsent Masons advises on Shackleton exit

Multinational law firm Pinsent Masons has advised the shareholders of independent financial advisory and wealth management firm Shackleton, including the private equity buy-and-build specialist Sovereign Capital Partners, on the exit to Lee Equity Partners.

Pinsent Masons named by The Times as a Top 50 Employer for Gender Equality

Multinational law firm Pinsent Masons has been announced by Business in the Community as one of The Times Top 50 Employers for Gender Equality in 2025. This year’s list marks the sixth time that the firm has been recognised for its commitment to embedding gender equality into all levels of the organisation.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises on funding of Vietnam’s first large-scale LNG-fueled power plants

Multinational law firm Pinsent Masons has advised PetroVietnam Power on the funding of the US$1.4 billion Nhon Trach 3 and Nhon Trach 4 LNG-to-Power plants, which will be the first large-scale LNG plants in Vietnam.

Pinsent Masons Announces Engagement with V7 Go to Enhance AI Capabilities

Multinational law firm Pinsent Masons has entered into an agreement with AI software firm, V7 Labs, to deploy their new GenAI automation platform, ‘V7 Go’.

Pinsent Masons appoints two partners and team of lawyers to launch TMT practice in Australia

Multinational law firm Pinsent Masons has appointed James Arnott and Veronica Scott and a team of lawyers to launch the firm’s Technology, Media and Telecommunications (TMT) practice in Australia.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.